Prescription drug · NDA
Furosemide NDC 10135-834
Furosemide 80 mg/1 · Tablet · Oral · Marlex Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 10135-834-01 | 10135083401 | 100 TABLET in 1 BOTTLE (10135-834-01)Marketed from Mar 1, 2026 | |
| 10135-834-05 | 10135083405 | 500 TABLET in 1 BOTTLE (10135-834-05)Marketed from Mar 1, 2026 | |
| 10135-834-90 | 10135083490 | 90 TABLET in 1 BOTTLE (10135-834-90)Marketed from Mar 1, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Furosemide
- Generic name (nonproprietary)
- furosemide
- Active ingredients
- Furosemide — 80 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Marlex Pharmaceuticals, Inc.NDC labeler code 10135
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 018569
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis at Loop of Henle (Physiologic effect)
- Identifiers
- Product ID 10135-834_4bd1ae61-8ab9-342a-e063-6394a90af1d2SPL ID 4bd1ae61-8ab9-342a-e063-6394a90af1d2SPL set ID 4bd1b15e-354e-051f-e063-6294a90a3f3bRxCUI 197732, 310429, 313988UNII 7LXU5N7ZO5
- Pharmacologic class
- Loop Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N410135083401followed by a unit qualifier and the quantityPackage 10135-0834-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Edema Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral Furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with Furosemide alone.
Excerpt only. Read the full label for complete information.
About NDC 10135-834
- What is NDC 10135-834?
- 10135-834 is the product NDC for Furosemide, Furosemide 80 mg/1 tablet, listed with the FDA by Marlex Pharmaceuticals, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Furosemide.
- What is the active ingredient?
- Furosemide.
- Who is the labeler?
- Marlex Pharmaceuticals, Inc., NDC labeler code 10135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Furosemide?
- 211 other product NDCs are listed under this name. See all Furosemide NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Furosemide products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | Civica, Inc. | 72572-275 | 72572-0275-10 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-033 | 87441-0033-01 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4679 | 70518-4679-00 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Coupler LLC | 67046-0768 | 67046-0768-03 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4609 | 70518-4609-00 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Coupler LLC | 67046-1663 | 67046-1663-03 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-832 | 10135-0832-0110135-0832-1010135-0832-90 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-833 | 10135-0833-0110135-0833-1010135-0833-90 |
| Furosemide | Furosemide 80 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0166 | 63561-0166-0163561-0166-0563561-0166-09 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0164 | 63561-0164-0163561-0164-0263561-0164-09 |
Other NDCs under NDA 018569
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Furosemide | Furosemide 40 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-833 |
| Furosemide | Furosemide 40 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0165 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0164 |
| Furosemide | Furosemide 80 mg/1 | TabletOral | Granulation Technology, Inc. | 63561-0166 |
| Furosemide | Furosemide 20 mg/1 | TabletOral | Marlex Pharmaceuticals, Inc. | 10135-832 |